2025 SPRING

Senior Executive

Conference

Advances in Longevity: From GLP-1s to Neurodegenerative Disease

May 4-6, 2025

Boston, MA

The Mandarin Oriental, Boston

2025 SPRING

Senior Executive

Conference

Advances in Longevity: From GLP-1s to Neurodegenerative Disease

May 4-6, 2025

Boston, MA

The Mandarin Oriental, Boston

ALDA’s 2025 Spring Senior Executive Conference will focus on the dynamic field of longevity science, highlighting breakthroughs from GLP-1s to advancements in neurodegenerative disease research. The programming will explore the latest developments in understanding and extending human healthspan, with insights on emerging therapies, biomarkers, and interventions poised to redefine aging. Join industry leaders as we examine how these innovations are transforming healthcare, drug development, and diagnostics.

Throughout the conference, attendees will experience unparalleled opportunities to connect with fellow leaders and top executives who are shaping the future of the industry.

 

ALDA’s semi-annual meetings are for presidents, CEOs, COOs, and senior executives from our member companies.

All times are EDT. Stay tuned for more program announcements.

Sunday, May 4

4:30-5:30 p.m. tentative
Reception for Women Executives; more details to come!

6-9:15 p.m.
Welcome reception and seated dinner with opening keynote speaker:

Mike_Pompeo

Mike Pompeo

70th Secretary of State (2018-2021), Former Director of the CIA (2017-2018)

Geopolitics in 2025: Insights from the Front Lines of U.S. Leadership

As the opening dinner speaker, former U.S. Secretary of State Mike Pompeo offers a unique perspective on the evolving political and economic landscape in the United States and beyond. With a new administration in Washington shaping policies and priorities, Pompeo will share insights into what these changes could mean for global relations, trade, and innovation. This session will explore critical geopolitical dynamics and offer a forward-looking view of opportunities and challenges for industries navigating a rapidly shifting world order, including a brief consideration of China’s role in the broader context.

Mike Pompeo served as the 70th U.S. Secretary of State from 2018 to 2021, where he played a pivotal role in shaping U.S. foreign policy during a time of significant global challenges. A graduate of the U.S. Military Academy at West Point and Harvard Law School, Pompeo’s career spans public service, the private sector, and leadership roles in national security and intelligence.

Prior to his role as Secretary of State, he served as the Director of the Central Intelligence Agency (CIA). Known for his sharp insights on global affairs, Pompeo continues to be a sought-after speaker on geopolitics and international strategy.

Monday, May 5

9 a.m. – 4:15 p.m.
“Advances in Longevity” programming. More speaker and session details will be announced soon.

Understanding GLP-1s: Progress, Potential, and What’s Next

 

Kicking off Monday’s sessions, Dan Brennan, Managing Director at TD Cowen, will deliver an insightful session on GLP-1 receptor agonists and their transformative impact on healthcare. This session will provide vital context on the rapidly evolving GLP-1 landscape, exploring its implications for life science tools and diagnostics companies. From market trends to R&D advancements, Brennan will highlight how these groundbreaking therapies are shaping opportunities and challenges for ALDA members.

 

Dan Brennan is a Managing Director and Senior Analyst at TD Cowen, specializing in life sciences and medical technology. With decades of experience in equity research and a reputation for deep industry expertise, he provides valuable strategic insights to stakeholders navigating the intersection of innovation and investment. Brennan’s ability to synthesize complex market trends and deliver actionable intelligence has made him a trusted advisor for leading companies in the healthcare and life sciences sectors.

Presented by:

Dan_Brennan

Dan Brennan
Managing Director
TD Cowen

Customer Perspective on GLP-1: Transforming Therapeutics and Diagnostics

 

Tentative. Speaker and sessions details to be announced soon.

Advancing Neurodegenerative Disease Research: Implications for Life Science Tools and Diagnostics

 

Tentative. Speaker and sessions details to be announced soon.

AI Meets Neuroscience: Accelerating Insights in Neurodegenerative Diseases

 

Anne Carpenter, Senior Director of the Imaging Platform at the Broad Institute, will present an engaging session on how her team is leveraging AI-driven technologies to tackle neurodegenerative diseases. Her groundbreaking work combines advanced image analysis with machine learning to uncover new biological insights, offering profound implications for understanding and treating conditions such as Alzheimer’s and Parkinson’s. Attendees will gain a glimpse into the cutting-edge intersection of AI, neuroscience, and precision medicine.

 

Anne Carpenter, PhD, is a pioneering scientist and Senior Director of the Imaging Platform at the Broad Institute of MIT and Harvard. Renowned for her innovative work in applying AI and machine learning to biological research, she is a leading figure in computational biology. Her lab’s open-source software, CellProfiler, has become a critical tool for image analysis in laboratories worldwide. Dr. Carpenter’s contributions have been recognized with numerous accolades, reflecting her dedication to advancing our understanding of complex diseases through interdisciplinary approaches.

Presented by:

Anne_Carpenter

Anne Carpenter, PhD
Institute Scientist & Senior Director, Imaging Platform
Broad Institute

Tuesday, May 6

8-9:15 a.m.
Keynote session with guest speaker:

Peter_Attia

Peter Attia, MD

Optimizing Healthspan: A Deep Dive into Longevity Science with Dr. Peter Attia

Join us for an engaging fireside chat with Dr. Peter Attia, physician, longevity expert, and author of the bestseller Outlive: The Science and Art of Longevity. Dr. Attia will delve into his comprehensive approach to extending human healthspan by addressing the “Four Horsemen” of chronic disease: heart disease, cancer, neurodegenerative disease, and metabolic dysfunction. Drawing from his extensive research and clinical experience, he will share actionable insights on how proactive strategies and cutting-edge medical advancements can combat these leading causes of mortality, offering a roadmap to not just living longer but living better.

This session is highly relevant for executives in diagnostics and life science tools companies, highlighting the critical role of innovation in early detection, prevention, and management of chronic diseases. Attendees will gain valuable perspectives on how advancements in technology and a deeper understanding of disease mechanisms can drive the future of healthcare and longevity. Bring your questions for a thought-provoking discussion that bridges the gap between scientific discovery and practical applications in the quest to extend human healthspan.

A physician renowned for his focus on the applied science of longevity, in Outlive, he challenges conventional medical thinking on aging and advocates for a proactive, preventative approach to health. His expertise spans metabolic disease, nutritional science, and neurodegeneration, making him uniquely positioned to speak on the intersection of these fields. Attendees will benefit from his deep knowledge and leave with a clearer vision of how to navigate and contribute to the rapidly evolving landscape of longevity science.

Dr. Attia earned his medical degree from Stanford University School of Medicine and completed five years of surgical training at Johns Hopkins Hospital. He also spent two years at the National Institutes of Health as a surgical oncology fellow at the National Cancer Institute.

First attendee from your company:
$2,795

Additional attendees from your company:
$2,295

No refunds of meeting registration fees will be made for registration cancellations after Thursday, April 24; however, if you must cancel, please remember that you are also responsible for canceling your hotel reservations.

Boston, Massachusetts, US
The Mandarin Oriental, Boston
776 Boylston St, Boston, MA 02199
Main Hotel Phone: (617) 535-8888

The Mandarin Oriental, Boston combines classic New England elegance with refined Oriental touches to create one of the most distinctive hospitality experiences in the region. A short 15-minute drive from Logan International Airport, the hotel connects guests to the city’s finest shopping, cultural venues, and business institutions from its prime location in the heart of Boston’s chic Back Bay on Boylston Street.

2024-spring-senior-executive-conference

Hotel Accommodations: ATTENDEES MUST MAKE THEIR OWN HOTEL RESERVATIONS.

Reserve your room online here. You also can email the Mandarin Oriental Boston Hotel or call them at (617) 535-8880 and reference “ALDA Spring Senior Executive Conference” or “Analytical, Life Science & Diagnostics Association.”

The special room rate of $545 per night for Deluxe King Rooms will be honored until our block is filled or Thursday, April 3, 2025.

Note: there may be penalties for rooms vacated prior to the scheduled departure date, and “no-show” reservations will be billed to your account for the full dates of the reservation. Reservation requests from attendees received less than thirty (30) days prior to our group’s arrival date will be accepted on a space and rate available basis at that time.

With questions, please contact Carol Starke, ALDA Meetings and Administration Manager, at (703) 282-0902, or email her directly.

What can I expect?

Opportunities to make valuable connections, gain strategic insights on emerging trends, and draw inspiration from industry-leading peers.

When is the conference?

The conference begins on Sunday, May 4 at 6 p.m. with a business-oriented speaker and dinner. The conference wraps up with our keynote speaker on Tuesday, May 6 around 9:15 a.m.

Who should attend?

Presidents, CEOs, COOs, and senior executives from ALDA member companies. Spouses are also welcome to attend the Sunday and Monday dinners and the closing session on May 6.

**This conference is for ALDA members only. If you are interested in attending and are a non-member, please contact ALDA staff regarding membership and the necessary next steps.

What is the cost to attend?

  • First attendee from your company: $2,795
  • Each additional attendee: $2,295

Where can I stay?

Attendees must make their own hotel reservations. ALDA has a room block at the conference host hotel, The Mandarin Oriental, Boston. Reserve a room online now; please see more details on the room block above, under “Location & Hotel Information.”

How do I register?

  1. Sign in to the website with your username and password. If you’re a member, you can reset your password here, if needed. Or, please contact us for assistance signing in.
  2. To register only yourself, select “Add Me.” Click “Save/Continue” to proceed through registration.
  3. Group registration: to register more than one person from your company and use one payment method for all registrants, use “Add Someone Else” to search for records in our system. If any registrant is not in our system, you can add them. Once all registrants are added, click “Save/Continue” to proceed through registration.

I have more questions – who can I contact?

Please email Carol Starke, ALDA Meetings and Administration Manager, or call her at (703) 282-0902 with any questions.